JP Morgan Maintains Neutral on Revvity, Raises Price Target to $165
JP Morgan analyst Casey Woodring maintains Revvity (NYSE:RVTY) with a Neutral and raises the price target from $160 to $165.
Last updated: 2026-11-18 19:40:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Revvity, Inc. (RVTY) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NYSE. The stock is currently priced at $151.74, with a market capitalization of $16.62B and a P/E ratio of 65.16. Over the past 52 weeks, its price has ranged from $81.22 to $171.74. This page covers its latest market performance, valuation, price trends and company information.
$16.62B | |
$146.66 | |
$153.11 | |
$146.66 | |
$147.79 | |
435.69K | |
1.95M | |
65.16 | |
$171.74 | |
$81.22 | |
0.19% | |
2026-10-04 |
Revvity, Inc. (RVTY) is currently trading at $151.74 as of 2026-11-18 19:24:26, up 2.96% ($4.38) from the previous close of $147.79
During today's regular trading session, RVTY has traded between $146.66 and $153.11, with a trading volume of 435.69K shares. The current price is near the upper end of today's range.
Over the past seven days, Revvity, Inc. (RVTY) moved from $160.72 to $151.74, representing a decline of 5.59% ($8.98).
The stock traded between $146.66 and $163.29 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.40 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 77.9%
RVTY is currently trading at $151.74, placing it 77.9% of the way from its 52-week low of $81.22 to its 52-week high of $171.74. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 11,000 |
| Exchange | NYSE |
| Company Website |
View the latest dividend and stock split events for Revvity, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | Jan 22, 2027 |
| Payment Date | Feb 12, 2027 |
| Dividend Per Share | $0.07 |
Latest news related to Revvity, Inc. and RVTY stock.
JP Morgan analyst Casey Woodring maintains Revvity (NYSE:RVTY) with a Neutral and raises the price target from $160 to $165.
In a comparison of two Medical Services stocks, Elevance Health (ELV) and Revvity (RVTY), both holding a Zacks Rank #2 (Buy), ELV emerges as the superior value option. ELV features a lower forward P/E ratio of 14.97 compared to RVTY's 29.34, a better PEG ratio of 2.08 versus 2.79, and a lower P/B ratio of 2.07 versus 2.44. These metrics contribute to ELV's Value grade of A compared to RVTY's C grade.
Eligible investors can buy real shares of Revvity, Inc. (RVTY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to RVTY, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between RVTY shares and USD.
RVTY Shares to USD
1.00 RVTY shares = 151.735 USD
Calculations are estimates based on the latest available price and are for reference only.